Table of Contents

Lemonade offers renters, home, auto, pet & life insurance in the USA and parts of Europe. The company’s tech-and-AI-native foundation cuts out hefty fixed costs associated with legacy models to lower cost of service. This enables it to routinely outcompete substitutes on price. It builds on this edge by obsessively iterating on its underwriting algorithms to ensure accurate underwriting. This has enabled brisk top-line scaling with stable fixed costs for a couple of years now. For a detailed review of its latest investor day, click here.

a. Key Points

  • Another quarter of accelerating demand growth.

  • Reiterated path to profitability.

  • Broad-based momentum across several products.

  • Great underwriting trends.

b. Demand

  • Beat In Force Premium (IFP) estimates by 1.4% & beat guidance by 1.3%.

  • Slightly beat Gross Earned Premium (GEP) estimates & beat guidance by 2%.

  • Beat revenue estimates by 4.8% & beat guidance by 3.9%.

  • Missed customer estimates by 1%. New customers for 2025 vs. 2024 rose by 25%.

Lemonade has now accelerated Y/Y IFP growth for 9 straight quarters. As I talk about constantly, it truly is a growth and margin puppet master. Its AI-native business model allows this insurance disruptor to rapidly scale with virtually no fixed cost growth. That frees it from reliance on a web of 3rd-party vendors built on ancient technology, which ensures it’s innovating faster than others – in AI and everywhere else. This is like the SoFi of insurance in terms of creating durable cost advantages in a sector where that has been traditionally hard to do.

Its marketing precision is reliably excellent, allowing it to predictably deploy dollars at a great 3X LTV/CAC. Its opportunity is so large that it hasn't come close to diminishing returns on these investments. And? Its product is so good that margin-accretive growth always follows more dollars spent. That’s how it has accelerated growth so consistently following the period of rampant inflation that forced it to slow down (to await rate change approvals). As soon as those changes came, Lemonade’s financials reacted.

  • As an important aside, it now has systems in place to be best-in-class for speed of rate update requests.

Note that a lower Y/Y rate of ceded premiums to reinsurers is currently propping up revenue growth. Lemonade’s rising confidence in its underwriting, profitability and liquidity all gave it the confidence to keep a larger portion of its overall demand. This means more revenue on the same base of premiums and, if done well in terms of pricing risk, should be a profit dollar accelerant as well. IFP and GEP growth both were strong and offer a better sense of demand right now, as both exclude that reinsurance comp noise.

  • This pattern of revenue growth greatly leading IFP and GEP growth will continue for 2026. Revenue growth should normalize back to ~30% in 2027 (in line with premiums).

c. Profits

  • Beat 40% GPM estimates by 910 basis points (bps; 1 basis point = 0.01%).

    • Gross profit rose by 73% Y/Y thanks to excellent loss ratio performance and great demand.

  • Beat -$12.8M EBITDA estimates by $8.2M & beat guidance by $10.1M.

  • Beat -$0.39 GAAP EPS estimates by $0.10.

    • -$0.29 in GAAP EPS vs. -$0.42 Y/Y.

  • Beat 63% gross loss ratio (GLR) estimates by 11 points; beat 64% net loss ratio (NLR) estimates by 11 points.

    • Prior period development impact (how actual claims compared to expected) was a favorable nine points for the quarter. It assumed losses would be higher than they were. All else equal, that also means loss ratio comps will be harder for Q4 2026.

    • GLR does not account for the reinsurance impact while NLR does. That’s the difference between the two metrics.

Lemonade continues to impressively control cost growth. Overall OpEx for Q4 grew by 33% Y/Y, which was 20 points slower than revenue. That facilitated ongoing margin improvements. Excluding loss adjustment expenses (LAE; costs to handle claims), OpEx rose by 24% Y/Y. That was almost entirely related to a 48% Y/Y boost to variable growth spend, which again continues to come with excellent returns.

And impressively, it has rapidly expanded while controlling fixed cost growth since 2022. OpEx excluding variable growth spend over the last 3 years has compounded at just a 5% clip; headcount fell by 6% during that time as well. It's a growth company. It's going to aggressively pursue more growth opportunities in 2026 and beyond. It will continue to favor investing more in new customers and plans if it enjoys better-than-expected efficiency. But? It will spend while ensuring cost growth greatly lags demand growth, allowing continued rapid operating leverage and a 2026 inflection. It’s a balancing act… and it’s an act Lemonade is performing masterfully.

  • R&D rose 14% Y/Y to $25M and G&A rose 29% Y/Y to $43M. That was driven by more stock comp from its rising share price, more interest expense to finance the added growth spending and a $5M bad debt expense. Keep an eye on whether or not that becomes a stubborn theme. For now, it's not.

  • LAE rose 24% Y/Y to $94.5M as LMND supports a larger business.

GLR and NLR can get noisy from quarter to quarter, which makes trailing 12-month (TTM) loss ratio data more valuable. Encouragingly, TTM GLR has improved for nine straight quarters. 

Finally, FCF is noisy here. As a reminder, Lemonade uses something called synthetic agents. These synthetic agents effectively finance its growth spend, which means the cash drain other companies would incur from marketing isn't immediately incurred by Lemonade. Instead, it pays an interest expense gradually over time. That makes Lemonade's FCF metric different from how most other companies calculate it. For this reason, I like to focus on income statement profitability, which also looks inevitable at this point. It felt inevitable a few years ago, but now that once polarizing take seems like it's the consensus view. 

d. Balance Sheet

  • $1.1B in cash & equivalents.

  • $250M regulatory surplus. It thinks this is more than sufficient to fund its current growth plans. 

  • No debt.

  • 4% Y/Y share dilution.

e. Annual Guidance & Valuation

logo

Subscribe to our premium content to read the rest.

Become a paying subscriber to get access to this post and a boatload of other subscriber-only content. Read the stock market newsletter read by Fortune 500 CEOs.

Upgrade

Reply

Avatar

or to participate